InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the full record of transactions filed by Levy Adam D.. Officer active across 1 company, notably Acrivon Therapeutics, Inc.. In total, 1 reports have been logged. History available since 1 August 2025. The latest transaction was filed on 1 August 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration